JOLIE WILSON: Open Payments
NPI 1831578749 · BREMEN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 14 payments from 7 companies in 2025. Trend: 2023 $2,170 · 2024 $2,104 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $166 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| ABBVIE INC. | 1 | $16 |
Products named: AUSTEDO XR, REXULTI, ABILIFY MAINTENA, SPRAVATO, CAPLYTA, UZEDY, VRAYLAR.
Industry payments across GA — which companies pay providers there.
